Related keylists
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes X2 insulin pump, basal-IQ technology, Control-IQ technology, software and applications, infusion sets and other pump accessories. In addition, it also offers connected health offerings. Tandem also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Canada, Australia, New Zealand, Saudi Arabia and South Africa. Tandem is headquartered in San Diego, California, the US.
Tandem Diabetes Care Inc premium industry data and analytics
Products and Services
Products |
---|
X2 Insulin Pump |
Infusion Set |
Software and Apps |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In February, the company introduced its new Tandem Mobi in the US. |
2023 | New Products/Services | In December, the company introduced Tandem Source. |
2023 | Contracts/Agreements | In December, the company partnered with Dexcom G7 Continuous Glucose Monitoring and launched updated t:slim X2 insulin pump software in the US. |
Competitor Comparison
Key Parameters | Tandem Diabetes Care Inc | Eli Lilly and Co | DexCom Inc | Insulet Corp | Medtronic MiniMed Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | San Diego | Indianapolis | San Diego | Acton | Los Angeles |
State/Province | California | Indiana | California | Massachusetts | California |
No. of Employees | 2,400 | 43,000 | 9,600 | 3,000 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Rebecca Robertso | Chairman | Executive Board | 2023 | 62 |
John F. Sheridan | Director; President; Chief Executive Officer | Executive Board | 2019 | 67 |
Leigh A. Vosseller | Chief Financial Officer; Treasurer; Executive Vice President | Senior Management | 2018 | 50 |
David B. Berger | Executive Vice President; Chief Operating Officer | Senior Management | 2022 | 53 |
Elizabeth Gasser | Chief Strategy Officer; Executive Vice President | Senior Management | 2021 | 47 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer